“…CD24 is broadly overexpressed on many types of tumor tissues, 60,84 including B-cell lymphomas, 85 erythroleukemia, 22 gliomas, 86 small cell lung cancer, 87 esophageal squamous cell carcinoma, 88 hepatocellular carcinoma, 89 cholangiocarcinoma, 90,91 pancreatic adenocarcinoma, 92 urothelial carcinoma, 93,94 ovarian cancer, 95 breast cancer, 28,96,97 primary neuroendocrine carcinomas 98 and prostate carcinomas. 99 Human cancer stem cells appear to have decreased expression of CD24 compared to their offspring; 100,101 however, it is unclear if the same pattern holds in mice.…”